Pneumococcal vaccines

Chen Fang Ho, Tzou Yien Lin

研究成果: 雜誌貢獻回顧型文獻

2 引文 (Scopus)

摘要

Streptococcus pneumoniae is the leading bacterial pathogen of infectious diseases in children and adolescents. The 23-valent pneumococcal polysaccharide vaccine could prevent invasive pneumococcal infection with broader serotype coverage but still has some limitations. On the other hand, 7-valent pneumococcal conjugate vaccine has been shown to decrease cases of nasopharyngeal acquired S. pneumoniae vaccine serotypes and proved herd immunity. The safety and efficacy against vaccine serotype pneumococcal diseases have been documented. However, the potential risk of increasing non-vaccine serotype pneumococcal diseases should be considered. This article reviews the current status of pneumococcal disease and pneumococcal vaccines. We also review the current situation of pneumococcal infections and vaccines in Taiwan. Surveillance of disease burden and clinical isolates should be continued.
原文英語
頁(從 - 到)765-772
頁數8
期刊Chang Gung Medical Journal
28
發行號11
出版狀態已發佈 - 十一月 2005
對外發佈Yes

指紋

Pneumococcal Vaccines
Pneumococcal Infections
Streptococcus pneumoniae
Herd Immunity
Conjugate Vaccines
Taiwan
Communicable Diseases
Vaccines
Safety
Serogroup

ASJC Scopus subject areas

  • Medicine(all)

引用此文

Pneumococcal vaccines. / Ho, Chen Fang; Lin, Tzou Yien.

於: Chang Gung Medical Journal, 卷 28, 編號 11, 11.2005, p. 765-772.

研究成果: 雜誌貢獻回顧型文獻

Ho, CF & Lin, TY 2005, 'Pneumococcal vaccines', Chang Gung Medical Journal, 卷 28, 編號 11, 頁 765-772.
Ho CF, Lin TY. Pneumococcal vaccines. Chang Gung Medical Journal. 2005 11月;28(11):765-772.
Ho, Chen Fang ; Lin, Tzou Yien. / Pneumococcal vaccines. 於: Chang Gung Medical Journal. 2005 ; 卷 28, 編號 11. 頁 765-772.
@article{013cc48a68004a8399a6ede2c5b7b5cb,
title = "Pneumococcal vaccines",
abstract = "Streptococcus pneumoniae is the leading bacterial pathogen of infectious diseases in children and adolescents. The 23-valent pneumococcal polysaccharide vaccine could prevent invasive pneumococcal infection with broader serotype coverage but still has some limitations. On the other hand, 7-valent pneumococcal conjugate vaccine has been shown to decrease cases of nasopharyngeal acquired S. pneumoniae vaccine serotypes and proved herd immunity. The safety and efficacy against vaccine serotype pneumococcal diseases have been documented. However, the potential risk of increasing non-vaccine serotype pneumococcal diseases should be considered. This article reviews the current status of pneumococcal disease and pneumococcal vaccines. We also review the current situation of pneumococcal infections and vaccines in Taiwan. Surveillance of disease burden and clinical isolates should be continued.",
keywords = "Acute otitis media, Invasive pneumococcal diseases, Penicillin-nonsusceptible Streptococcus pneumoniae, Pneumococcal conjugate vaccine, Pneumococcal polysaccharide vaccine",
author = "Ho, {Chen Fang} and Lin, {Tzou Yien}",
year = "2005",
month = "11",
language = "English",
volume = "28",
pages = "765--772",
journal = "Chang Gung Medical Journal",
issn = "0255-8270",
publisher = "Chang Gung Medical Journal",
number = "11",

}

TY - JOUR

T1 - Pneumococcal vaccines

AU - Ho, Chen Fang

AU - Lin, Tzou Yien

PY - 2005/11

Y1 - 2005/11

N2 - Streptococcus pneumoniae is the leading bacterial pathogen of infectious diseases in children and adolescents. The 23-valent pneumococcal polysaccharide vaccine could prevent invasive pneumococcal infection with broader serotype coverage but still has some limitations. On the other hand, 7-valent pneumococcal conjugate vaccine has been shown to decrease cases of nasopharyngeal acquired S. pneumoniae vaccine serotypes and proved herd immunity. The safety and efficacy against vaccine serotype pneumococcal diseases have been documented. However, the potential risk of increasing non-vaccine serotype pneumococcal diseases should be considered. This article reviews the current status of pneumococcal disease and pneumococcal vaccines. We also review the current situation of pneumococcal infections and vaccines in Taiwan. Surveillance of disease burden and clinical isolates should be continued.

AB - Streptococcus pneumoniae is the leading bacterial pathogen of infectious diseases in children and adolescents. The 23-valent pneumococcal polysaccharide vaccine could prevent invasive pneumococcal infection with broader serotype coverage but still has some limitations. On the other hand, 7-valent pneumococcal conjugate vaccine has been shown to decrease cases of nasopharyngeal acquired S. pneumoniae vaccine serotypes and proved herd immunity. The safety and efficacy against vaccine serotype pneumococcal diseases have been documented. However, the potential risk of increasing non-vaccine serotype pneumococcal diseases should be considered. This article reviews the current status of pneumococcal disease and pneumococcal vaccines. We also review the current situation of pneumococcal infections and vaccines in Taiwan. Surveillance of disease burden and clinical isolates should be continued.

KW - Acute otitis media

KW - Invasive pneumococcal diseases

KW - Penicillin-nonsusceptible Streptococcus pneumoniae

KW - Pneumococcal conjugate vaccine

KW - Pneumococcal polysaccharide vaccine

UR - http://www.scopus.com/inward/record.url?scp=30444460588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30444460588&partnerID=8YFLogxK

M3 - Review article

C2 - 16422182

AN - SCOPUS:30444460588

VL - 28

SP - 765

EP - 772

JO - Chang Gung Medical Journal

JF - Chang Gung Medical Journal

SN - 0255-8270

IS - 11

ER -